Abstract
Herein we describe the use of intracavernous methylene blue (MB), a guanylate cyclase inhibitor, or internal pudendal artery embolization for the treatment of priapism. Eleven patients with priapism were treated from 1993-1996. Etiologies of priapism included PGE1/papaverine (3), trazodone (2), and sickle cell disease (1), in the other five cases the causes the cause was unknown. The average duration of priapism was 27 h for all patients (6-72 h). Five patients who failed intracavernous MB or an alpha-adrenergic agonist, underwent unilateral or bilateral pudendal artery embolization. The average duration of priapism for patients undergoing embolization was 43 h. Sixty-seven percent of the patients treated with MB responded with immediate detumescence. One-hundred percent of patients with priapism secondary to intracavernous injection therapy or trazodone responded. Of the five patients who underwent embolization, 40% achieved immediate pain relief and subsequent detumescence. The three non-responders exhibited a partial detumescence over 47-72 h. After follow-up of one year embolization available for only two patients revealed that one regained potency while the other remained impotent. These results confirmed that MB is effect...Continue Reading
Citations
Jan 21, 2006·The Journal of Sexual Medicine·Chris McMahon
Jan 21, 2006·The Journal of Sexual Medicine·Ahmed AteyahHatem Saad El-Den
Dec 3, 2003·Expert Opinion on Pharmacotherapy·Zafar MaanHitendra R H Patel
Mar 5, 2005·International Braz J Urol : Official Journal of the Brazilian Society of Urology·C Van der HorstK P Juenemann
Aug 23, 2003·International Journal of Impotence Research·C M EarleZ S Wisniewski
Jun 26, 2002·BJU International·S R KeoghaneM A W Miller
Mar 29, 2002·International Journal of Impotence Research·T H BschleipferW Weidner
Nov 1, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Magalie Lenoir, Serge H Ahmed
Apr 17, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Virginia H HuxleyIngrid H Sarelius
Dec 13, 2007·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·V De Micco, G Aronne
Dec 29, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Joseph P Mizgerd, Shawn J Skerrett
Feb 12, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Christian MühlfeldPeter Gehr
Apr 25, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·F Breyer
Mar 1, 2014·Augmentative and Alternative Communication : AAC·Janice Light, David McNaughton
Apr 1, 2003·Language, Speech, and Hearing Services in Schools·Lyn TurkstraChristine Seaton
Feb 20, 2014·TheScientificWorldJournal·Biji ShibulalSanket J Joshi
Mar 17, 2001·The British Journal of Dermatology·B ZeinaB Das
Jan 22, 2000·Andrologia·F J Martínez Portillo, K P Jünemann